Compass Pathways Stock (NASDAQ: CMPS) stock price, news, charts, stock research, profile.
Open | $8.780 |
Close | $7.860 |
Volume / Avg. | 623.166K / 646.497K |
Day Range | 7.840 - 8.790 |
52 Wk Range | 5.010 - 12.750 |
Market Cap | $562.493M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 5.86% |
Days to Cover | 5.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Compass Pathways (NASDAQ: CMPS) through any online brokerage.
Other companies in Compass Pathways’s space includes: Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).
The latest price target for Compass Pathways (NASDAQ: CMPS) was reported by Cantor Fitzgerald on Tuesday, April 30, 2024. The analyst firm set a price target for 0.00 expecting CMPS to fall to within 12 months (a possible -100.00% downside). 18 analyst firms have reported ratings in the last year.
The stock price for Compass Pathways (NASDAQ: CMPS) is $8.2305 last updated May 10, 2024 at 6:30 PM EDT.
There are no upcoming dividends for Compass Pathways.
Compass Pathways’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Compass Pathways.
Compass Pathways is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.